Carcinoma ex pleomorphic adenoma of the parotid gland: a case with difficult diagnosis

Sridhar Reddy Dandala; Vinod Kumar Gonuru; Vidhi Gandhi

doi:10.18203/2320-6012.ijrms20244157

Authors

Sridhar Reddy Dandala Department of Otorhinolaryngology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India
Vinod Kumar Gonuru Department of Otorhinolaryngology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India
Vidhi Gandhi Department of Otorhinolaryngology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20244157

Keywords:

Carcinoma ex pleomorphic adenoma, CXPA, Non-invasive, Pleomorphic adenoma, Parotid gland

Abstract

Carcinoma ex pleomorphic adenoma (CXPA) is carcinoma arising from a primary or recurrent benign pleomorphic adenoma. It might be non-invasive or invasive. It often poses a diagnostic challenge to clinicians and pathologists. Pathological assessment is the gold standard for diagnosis. Treatment for CXPA often involves an ablative surgical procedure, which may be followed by radiotherapy. We report to you a 63-year-old female who came to the ENT OPD with a complaint of swelling in the front of the right ear for 6 months and pain over swelling for 2 weeks. The patient was advised for USG-guided FNAC, which was suggestive of a benign cystic parotid lesion. The patient was planned for superficial parotidectomy and the tumor was surgically excised. The frozen section was suggestive of a benign salivary gland tumor and the histopathology report concluded of a non-invasive carcinoma ex pleomorphic adenoma. The patient was advised to undergo radiotherapy after the surgery. During the follow-up, the patient showed signs of Frey’s syndrome. Carcinoma ex pleomorphic adenoma is difficult to diagnose; clinicians and pathologists should work together to diagnose it and pathological assessment is the gold standard for the diagnosis.

Metrics

Metrics Loading ...

References

Keerthi R, Raut RP, Vaibhav N, Ghosh A. Carcinoma ex pleomorphic adenoma: Diagnostic dilemma and treatment protocol. Indian Journal of Dentistry. 2014;5(3):157.

Nouraei SA, Hope KL, Kelly CG, McLean NR, Soames JV. Carcinoma ex benign pleomorphic adenoma of the parotid gland. Plastic and reconstructive surgery. 2005;116(5):1206-13.

Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, Ménard M, Brasnu D. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25‐year experience with 229 patients. The Laryngoscope. 1994;104(12):1487-94.

Antony J, Gopalan V, Smith RA, Lam AK. Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head and neck pathology. 2012;6:1-9.

Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus‐Coll BM, Keus RB, van Leeuwen FE, Hart AA. The development of a prognostic score for patients with parotid carcinoma. Cancer: Interdisciplinary Int J Am Cancer Society. 1999;85(9):2057-67.

Ghaloo SK, Qayyum MU, Shaikh OS, Faisal M, Keerio AA, Hussain RT. Carcinoma ex-pleomorphic adenoma of mandible: A case report and review of literature. International Journal of Surgery Case Reports. 2022;100:107729.

Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head & Neck: Journal for the Sciences and Specialties of the Head and Neck. 2001;23(9):705-12.

Scognamiglio T, Joshi R, Kuhel WI, Tabbara SO, Rezaei MK, Hoda RS. Noninvasive carcinoma ex pleomorphic adenoma of the parotid gland: A difficult diagnosis on fine needle aspiration. Cytojournal. 2015;12.

Srinivas CV. Carcinoma ex-pleomorphic adenoma: a case for cure. Int J Head and Neck Surg. 2020;11(2):32-5.

Katabi N, Gomez D, Klimstra DS, Carlson DL, Lee N, Ghossein R. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Human Pathol. 2010;41(7):927-34.